Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Altcoin Season Signals Strength as Golden Cross Holds

Altcoin Season Signals Strength as Golden Cross Holds

CoinCryptoNewzCoinCryptoNewz2026/07/21 14:45
By:CoinCryptoNewz
  • Moustache says the altcoin accumulation window is narrowing.
  • Javon Marks identifies a confirmed macro Golden Cross.
  • Historical patterns resemble the 2017 and 2021 altcoin rallies.

Altcoin Season is back in focus after two crypto analysts highlighted technical signals that closely resemble previous market cycles. Analyst Moustache believes the window for accumulating altcoins is narrowing, while Javon Marks argues the market has entered the early stages of a new altseason following a confirmed macro Golden Cross.

Altcoin Season Supported by Strong Market Structure

According to Moustache, the total cryptocurrency market capitalization continues to hold above the $3 trillion regime level. The weekly chart also shows price remaining above the 200-week EMA, while the 300-week moving average continues to act as a long-term market bottom.

Altcoin Season Signals Strength as Golden Cross Holds image 0

The analyst noted that the current structure resembles previous bull market formations, including a double-bottom pattern where former resistance has turned into support. Similar setups appeared before major expansion phases in earlier market cycles. Based on this pattern, Moustache suggested the opportunity to accumulate before Altcoin Season fully develops may be closing.

Altcoin Season Gains Further Support From Golden Cross

Crypto analyst Javon Marks shared a TradingView chart comparing the current market with the altcoin rallies of 2017 and 2021. His analysis highlighted a second Golden Cross, which has remained intact after forming.

With Altcoins Macro Setup showing a clear + holden second Golden Cross, we, per technicals, continue to see Alt Season to be in early stages of commencement RIGHT NOW!

The most bullish season for alts look to be here people, just hold on…#Altcoins

— JAVON⚡️MARKS (@JavonTM1)

Marks believes this technical signal mirrors previous cycles that led to substantial gains across the altcoin market. He added that the current Altcoin Season appears to be in its earliest phase, with historical price behavior supporting the possibility of broader market expansion.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

The "Outlier" Investment Art in the New Era of Berky

他山之石观投资2026/09/14 09:22
The "Outlier" Investment Art in the New Era of Berky

Chevron (CVX.US) explores alternative hedging for Middle East supply disruptions: targets Argentina and the Mediterranean to drive global LNG growth, seeks deal with India

Chevron is focusing on Argentina and the Mediterranean region, seeking global growth in liquefied natural gas, and plans to reach an agreement with India.

智通财经2026/09/14 09:12
Chevron (CVX.US) explores alternative hedging for Middle East supply disruptions: targets Argentina and the Mediterranean to drive global LNG growth, seeks deal with India

Energy and food price pressures intensify, potentially triggering an inflation rebound! The Bank of England may struggle to remain "calm" as market rate hike bets surge

The upward pressure on energy prices caused by the unresolved Middle East war is mounting. New risks are also approaching, which may keep inflation above the Bank of England’s 2% target for most of next year.

智通财经2026/09/14 08:57
Energy and food price pressures intensify, potentially triggering an inflation rebound! The Bank of England may struggle to remain "calm" as market rate hike bets surge

AstraZeneca (AZN.US) Breast Cancer Drug Etcamah Faces Setback in Phase III Clinical Trial, Potentially Impacting Billions in Sales

Bloomberg Intelligence analyst John Murphy stated that the setback in AstraZeneca's breast cancer drug trial could reduce sales in 2035 by $2.6 billion to $3.8 billion.

智通财经2026/09/14 08:41
AstraZeneca (AZN.US) Breast Cancer Drug Etcamah Faces Setback in Phase III Clinical Trial, Potentially Impacting Billions in Sales